Sleep deprivation and central appetite regulation
Mientras que algunos pacientes pueden perder inters en el sexo, otros pueden tener la experiencia opuesta
doi: 10.3389/fmed.2025.1638981 Received 31 May 2025 Accepted 14 August 2025 Published 10 September 2025 Volume 12 - 2025 Edited by Iain Brownlee, Northumbria University, United Kingdom Reviewed by Qianqian Zhang, Anhui University of Chinese Medicine, China Ion Hobai, Massachusetts General Hospital and Harvard Medical School, United States Updates Copyright 2025 Ukwade, Hernandez, Modi, Raza, Siegel, Nwachukwu, Sarraf, Memon, Booth, Cooper, Boulay and Mutlu
Additionally, females experienced greater pain relief than males, suggesting a potential gender-specific response to the treatment [62]
With the popularity of GLP-1 agonists ever-increasing and over 150 GLP-1 drug candidates in development [3], the field is continually expanding, most recently into oncology and obesity-related cancers.[4] While most approved GLP-1RAs require subcutaneous injection, substantial work is being undertaken to move toward oral GLP-1 therapies [5], such as Rybelsus which was the first oral GLP-1RA approved by the FDA in 2019